首页> 外文期刊>Pharmaceutical research >Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.
【24h】

Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.

机译:肝素固定的多孔PLGA微球用于血管生成生长因子的递送。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Heparin immobilized porous poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres were prepared for sustained release of basic fibroblast growth factor (bFGF) to induce angiogenesis. MATERIALS AND METHODS: Porous PLGA microspheres having primary amine groups on the surface were prepared using an oil-in-water (O/W) single emulsion method using Pluronic F-127 as an extractable porogen. Heparin was surface immobilized via covalent conjugation. bFGF was loaded into the heparin functionalized (PLGA-heparin) microspheres by a simple dipping method. The bFGF loaded PLGA-heparin microspheres were tested for in vitro release and in vivo angiogenic activity. RESULTS: PLGA microspheres with an open-porous structure were formed. The amount of conjugated amine group onto the microspheres was 1.93+/-0.01 nmol/mg-microspheres, while the amount of heparin was 95.8 pmol/mg-microspheres. PLGA-heparin microspheres released out bFGF in a more sustained manner with a smaller extent of initial burst than PLGA microspheres, indicating that surface immobilized heparin controlled the release rate of bFGF. Subcutaneous implantation of bFGF loaded PLGA-heparin microspheres in mice significantly induced the formation of new vascular microvessels. CONCLUSIONS: PLGA microspheres with an open porous structure allowed significant amount of heparin immobilization and bFGF loading. bFGF loaded PLGA-HP microspheres showed sustained release profiles of bFGF in vitro, demonstrating reversible and specific binding of bFGF to immobilized heparin. They also induced local angiogenesis in vivo in an animal model.
机译:目的:制备固定有肝素的多孔聚(D,L-乳酸-乙醇酸)(PLGA)微球,以持续释放碱性成纤维细胞生长因子(bFGF)以诱导血管生成。材料与方法:使用Pluronic F-127作为可萃取成孔剂,采用水包油(O / W)单乳液法制备表面具有伯胺基的多孔PLGA微球。肝素通过共价结合被表面固定。通过简单的浸渍方法将bFGF加载到肝素功能化(PLGA-肝素)微球中。测试了载有bFGF的PLGA-肝素微球的体外释放和体内血管生成活性。结果:形成了具有开孔结构的PLGA微球。微球上的共轭胺基的量为1.93 +/- 0.01nmol / mg-微球,而肝素的量为95.8pmol / mg-微球。与PLGA微球相比,PLGA-肝素微球以更持久的方式释放bFGF,初始爆发程度更小,表明表面固定的肝素控制着bFGF的释放速率。皮下植入负载bFGF的PLGA-肝素微球在小鼠中显着诱导了新血管微血管的形成。结论:具有开放的多孔结构的PLGA微球允许大量的肝素固定和bFGF负载。载有bFGF的PLGA-HP微球在体外显示bFGF的持续释放曲线,表明bFGF与固定的肝素具有可逆和特异性结合。他们还在动物模型中诱导了体内局部血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号